These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35348739)

  • 1. Incidence and predictors of severe altitude illness symptoms in Mt. Kilimanjaro hikers: a prospective cohort study.
    Croughs M; Nyakunga GB; Sakita FM; Kilonzo K; Mmbaga BT; Soentjens P
    J Travel Med; 2022 Aug; 29(5):. PubMed ID: 35348739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Determinants of Acute Mountain Sickness and Summit Success on a 6-Day Ascent of Mount Kilimanjaro (5895 m).
    Lawrence JS; Reid SA
    Wilderness Environ Med; 2016 Mar; 27(1):78-84. PubMed ID: 26948557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious altitude illness in travelers who visited a pre-travel clinic.
    Croughs M; Van Gompel A; Rameckers S; Van den Ende J
    J Travel Med; 2014; 21(6):403-9. PubMed ID: 25238200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of acute mountain sickness on Mt. Kilimanjaro using trekking company data.
    Eigenberger P; Faino A; Maltzahn J; Lisk C; Frank E; Frank A; Loomis Z; Schroeder T; Strand M; Irwin D
    Aviat Space Environ Med; 2014 Nov; 85(11):1125-9. PubMed ID: 25329946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
    Davies AJ; Kalson NS; Stokes S; Earl MD; Whitehead AG; Frost H; Tyrell-Marsh I; Naylor J
    Wilderness Environ Med; 2009; 20(4):311-7. PubMed ID: 20030437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetazolamide in prevention of acute mountain sickness: a double-blind controlled cross-over study.
    Greene MK; Kerr AM; McIntosh IB; Prescott RJ
    Br Med J (Clin Res Ed); 1981 Sep; 283(6295):811-3. PubMed ID: 6794709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altitude-Related Disorders on Mount Kilimanjaro, Tanzania: Two-Year Survey in a Local Referral Center.
    Dekker MCJ; Mremi A; Kilonzo KG; Nyakunga G; Sakita F; Mvungi M; Urasa SJ; Masenga G; Howlett WP
    Wilderness Environ Med; 2021 Mar; 32(1):36-40. PubMed ID: 33431301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of acute mountain sickness among Finnish trekkers on Mount Kilimanjaro, Tanzania: an observational study.
    Karinen H; Peltonen J; Tikkanen H
    High Alt Med Biol; 2008; 9(4):301-6. PubMed ID: 19115914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mt. Whitney: determinants of summit success and acute mountain sickness.
    Wagner DR; D'Zatko K; Tatsugawa K; Murray K; Parker D; Streeper T; Willard K
    Med Sci Sports Exerc; 2008 Oct; 40(10):1820-7. PubMed ID: 18799993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Use Among Mount Everest Climbers: Practice and Attitudes.
    Luks AM; Grissom C; Freer L; Hackett P
    High Alt Med Biol; 2016 Dec; 17(4):315-322. PubMed ID: 27763796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness.
    Leshem E; Caine Y; Rosenberg E; Maaravi Y; Hermesh H; Schwartz E
    J Travel Med; 2012; 19(5):308-10. PubMed ID: 22943271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal.
    Newcomb L; Sherpa C; Nickol A; Windsor J
    Wilderness Environ Med; 2011 Sep; 22(3):197-201. PubMed ID: 21962045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. History of Migraine Predicts Headache at High Altitude.
    Davis C; Reno E; Maa E; Roach R
    High Alt Med Biol; 2016 Dec; 17(4):300-304. PubMed ID: 27788038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro.
    Jackson SJ; Varley J; Sellers C; Josephs K; Codrington L; Duke G; Njelekela MA; Drummond G; Sutherland AI; Thompson AA; Baillie JK
    High Alt Med Biol; 2010; 11(3):217-22. PubMed ID: 20919888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute mountain sickness in travelers who consulted a pre-travel clinic.
    Croughs M; Van Gompel A; Van den Ende J
    J Travel Med; 2011; 18(5):337-43. PubMed ID: 21896098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5,895 m).
    Kalson NS; Thompson J; Davies AJ; Stokes S; Earl MD; Whitehead A; Tyrrell-Marsh I; Frost H; Montgomery H
    Eur J Appl Physiol; 2009 Feb; 105(3):373-9. PubMed ID: 19030872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance of Organ Transplant Recipients to Physical Activity during a High-Altitude Expedition: Climbing Mount Kilimanjaro.
    van Adrichem EJ; Siebelink MJ; Rottier BL; Dilling JM; Kuiken G; van der Schans CP; Verschuuren EA
    PLoS One; 2015; 10(11):e0142641. PubMed ID: 26606048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myopic Changes in a Climber after Taking Acetazolamide and the Use of Corrective Lenses to Temporize Symptoms: A Case Report from Mount Kilimanjaro.
    Hill AD
    Wilderness Environ Med; 2016 Sep; 27(3):397-400. PubMed ID: 27397528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-daily assessment of trekkers on Kilimanjaro's Machame route to evaluate the incidence and time-course of acute mountain sickness.
    Meyer J
    High Alt Med Biol; 2012 Dec; 13(4):281-4. PubMed ID: 23270446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetazolamide in prevention of acute mountain sickness.
    McIntosh IB; Prescott RJ
    J Int Med Res; 1986; 14(5):285-7. PubMed ID: 3533677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.